Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy
Laurène M. André, C. Rosanne M. Ausems, Derick G. Wansink, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Muscle‐specific gene editing improves molecular and phenotypic defects in a mouse model of myotonic dystrophy type 1
Mariapaola Izzo, Jonathan Battistini, Elisabetta Golini, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access | Times Cited: 2
Contributions of alternative splicing to muscle type development and function
Elena Nikonova, Shao-Yen Kao, Maria L. Spletter
Seminars in Cell and Developmental Biology (2020) Vol. 104, pp. 65-80
Open Access | Times Cited: 49
Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing
Mariapaola Izzo, Jonathan Battistini, Claudia Provenzano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4622-4622
Open Access | Times Cited: 24
miR-7 Restores Phenotypes in Myotonic Dystrophy Muscle Cells by Repressing Hyperactivated Autophagy
María Sabater-Arcis, Ariadna Bargiela, Denis Furling, et al.
Molecular Therapy — Nucleic Acids (2019) Vol. 19, pp. 278-292
Open Access | Times Cited: 38
Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity
Christopher R. S. Banerji, Don Henderson, Rabi Tawil, et al.
Human Molecular Genetics (2020) Vol. 29, Iss. 16, pp. 2746-2760
Open Access | Times Cited: 38
CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities
Renée H.L. Raaijmakers, Lise Ripken, C. Rosanne M. Ausems, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 15, pp. 3689-3689
Open Access | Times Cited: 31
Aberrant insulin receptor expression is associated with insulin resistance and skeletal muscle atrophy in myotonic dystrophies
Laura Valentina Renna, Francesca Bosè, Elisa Brigonzi, et al.
PLoS ONE (2019) Vol. 14, Iss. 3, pp. e0214254-e0214254
Open Access | Times Cited: 30
Targeting Myotonic Dystrophy Type 1 with Metformin
Mikel García-Puga, Ander Saenz‐Antoñanzas, Ander Matheu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2901-2901
Open Access | Times Cited: 18
Altered myogenesis and premature senescence underlie human TRIM32-related myopathy
Emilia Servián‐Morilla, Macarena Cabrera‐Serrano, Eloy Rivas, et al.
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 29
Continuous exposure of isoprenaline inhibits myoblast differentiation and fusion through PKA/ERK1/2-FOXO1 signaling pathway
Shaojuan Chen, Yue Jing, Jingxuan Zhang, et al.
Stem Cell Research & Therapy (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 27
Myogenic, genomic and non‐genomic influences of the vitamin D axis in skeletal muscle
Shelby E. Bollen, Philip J. Atherton
Cell Biochemistry and Function (2020) Vol. 39, Iss. 1, pp. 48-59
Open Access | Times Cited: 27
Including glutamine in a resource allocation model of energy metabolism in cancer and yeast cells
Jan Ewald, Ziyang He, Wassili Dimitriew, et al.
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Conserved functions of RNA-binding proteins in muscle
Elena Nikonova, Shao-Yen Kao, Keshika Ravichandran, et al.
The International Journal of Biochemistry & Cell Biology (2019) Vol. 110, pp. 29-49
Closed Access | Times Cited: 23
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study
Alessia Perna, Daria Maccora, Salvatore Rossi, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 22
Dynamic Changes to the Skeletal Muscle Proteome and Ubiquitinome Induced by the E3 Ligase, ASB2β
Craig A. Goodman, Jonathan R. Davey, Adam Hagg, et al.
Molecular & Cellular Proteomics (2021) Vol. 20, pp. 100050-100050
Open Access | Times Cited: 20
Skeletal Muscle Mitochondria Dysfunction in Genetic Neuromuscular Disorders with Cardiac Phenotype
Elena Ignatieva, Natalia Smolina, Anna Kostareva, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7349-7349
Open Access | Times Cited: 19
Impaired muscle stem cell function and abnormal myogenesis in acquired myopathies
Alyson Deprez, Zakaria Orfi, Lupann Rieger, et al.
Bioscience Reports (2022) Vol. 43, Iss. 1
Open Access | Times Cited: 12
Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG)n Repeat
Laurène M. André, Remco T. P. van Cruchten, Marieke Willemse, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5685-5685
Open Access | Times Cited: 19
Transcriptomic Profile of Primary Culture of Skeletal Muscle Cells Isolated from Semitendinosus Muscle of Beef and Dairy Bulls
Anna Ciecierska, T. Motyl, Tomasz Sadkowski
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 13, pp. 4794-4794
Open Access | Times Cited: 17
Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy
Yan Gu, Andrea Rampin, Valeria Vincenza Alvino, et al.
Current Diabetes Reports (2021) Vol. 21, Iss. 3
Open Access | Times Cited: 16
Cellular Senescence and Aging in Myotonic Dystrophy
Yuhei Hasuike, Hideki Mochizuki, Masayuki Nakamori
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2339-2339
Open Access | Times Cited: 11
Combinatorial treatment with exercise and AICAR potentiates the rescue of myotonic dystrophy type 1 mouse muscles in a sex-specific manner
Naomi S Misquitta, Aymeric Ravel‐Chapuis, Bernard J. Jasmin
Human Molecular Genetics (2022) Vol. 32, Iss. 4, pp. 551-566
Closed Access | Times Cited: 10
Clinical and Molecular Insights into Gastrointestinal Dysfunction in Myotonic Dystrophy Types 1 & 2
Janel Peterson, Thomas A. Cooper
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14779-14779
Open Access | Times Cited: 10
Systemic cell therapy for muscular dystrophies
C. Rosanne M. Ausems, Baziel G.M. van Engelen, Hans van Bokhoven, et al.
Stem Cell Reviews and Reports (2020) Vol. 17, Iss. 3, pp. 878-899
Open Access | Times Cited: 14
Characterization of stress response involved in chicken myopathy
Seong Wook Kang, Michael T. Kidd, Hakeem J. Kadhim, et al.
General and Comparative Endocrinology (2020) Vol. 295, pp. 113526-113526
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top